147 related articles for article (PubMed ID: 3022270)
1. Successful control of Cushing's disease in the elderly with long term metyrapone.
Donckier J; Burrin JM; Ramsay ID; Joplin GF
Postgrad Med J; 1986 Aug; 62(730):727-30. PubMed ID: 3022270
[TBL] [Abstract][Full Text] [Related]
2. Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome.
Verhelst JA; Trainer PJ; Howlett TA; Perry L; Rees LH; Grossman AB; Wass JA; Besser GM
Clin Endocrinol (Oxf); 1991 Aug; 35(2):169-78. PubMed ID: 1657460
[TBL] [Abstract][Full Text] [Related]
3. Primary therapy for Cushing's disease with metyrapone.
Dickstein G; Lahav M; Shen-Orr Z; Edoute Y; Barzilai D
JAMA; 1986 Mar; 255(9):1167-9. PubMed ID: 3003415
[TBL] [Abstract][Full Text] [Related]
4. Metyrapone for Cushing's syndrome.
Inagaki M; Akizuki N; Kugaya A; Fujii H; Akechi T; Uchitomi Y
Am J Psychiatry; 2002 Jul; 159(7):1246. PubMed ID: 12091216
[No Abstract] [Full Text] [Related]
5. ACTH-independent Cushing's syndrome in pregnancy with spontaneous resolution after delivery: control of the hypercortisolism with metyrapone.
Close CF; Mann MC; Watts JF; Taylor KG
Clin Endocrinol (Oxf); 1993 Sep; 39(3):375-9. PubMed ID: 8222300
[TBL] [Abstract][Full Text] [Related]
6. Drug controlled of Cushing's syndrome. Combined aminoglutethimide and metyrapone therapy.
Child DF; Burke CW; Burley DM; Rees LH; Fraser TR
Acta Endocrinol (Copenh); 1976 Jun; 82(2):330-41. PubMed ID: 179256
[TBL] [Abstract][Full Text] [Related]
7. [Adrenostatic treatment of ACTH-dependent Cushing syndrome using metyrapone and aminoglutethimide].
Reincke M; Allolio B; Jaursch-Hancke C; Kaulen D; Winkelmann W
Dtsch Med Wochenschr; 1987 Oct; 112(40):1532-5. PubMed ID: 2820688
[TBL] [Abstract][Full Text] [Related]
8. Effects of cyproheptadine and metyrapone on ACTH and aldosterone concentrations in patients with Cushing's disease: a preliminary report.
Zgliczyński S; Kozłowicz I; Wilczyńska J; Baranowska B
Mater Med Pol; 1980; 12(1-2):85-90. PubMed ID: 6276625
[No Abstract] [Full Text] [Related]
9. Treatment of Cushing's disease with adrenal blocking drugs and megavoltage therapy to the pituitary.
Hunter PR; Ross W; Hall R; Cook DB
Proc R Soc Med; 1974 Dec; 67(12 Pt 1):1225. PubMed ID: 4375290
[No Abstract] [Full Text] [Related]
10. Metyrapone for delirium due to Cushing's syndrome induced by occult ectopic adrenocorticotropic hormone secretion.
Kawashima T; Oda M; Kuno T; Ueki H; Yamada S; Hisatomi A
J Clin Psychiatry; 2004 Jul; 65(7):1019-20. PubMed ID: 15291697
[No Abstract] [Full Text] [Related]
11. The combined use of sodium valproate and metyrapone in the treatment of Cushing's syndrome.
Nussey SS; Price P; Jenkins JS; Altaher AR; Gillham B; Jones MT
Clin Endocrinol (Oxf); 1988 Apr; 28(4):373-80. PubMed ID: 2847889
[TBL] [Abstract][Full Text] [Related]
12. Metyrapone in long-term management of Cushing's disease.
Jeffcoate WJ; Rees LH; Tomlin S; Jones AE; Edwards CR; Besser GM
Br Med J; 1977 Jul; 2(6081):215-7. PubMed ID: 195666
[TBL] [Abstract][Full Text] [Related]
13. Prolonged remission in florid Cushing's syndrome following metyrapone treatment.
Beardwell CG; Adamson AR; Shalet SM
Clin Endocrinol (Oxf); 1981 May; 14(5):485-92. PubMed ID: 6273022
[TBL] [Abstract][Full Text] [Related]
14. ACTH and cortisol response to bromocriptine, and results of long-term therapy, in Cushing's disease.
Kennedy AL; Sheridan B; Montgomery DA
Acta Endocrinol (Copenh); 1978 Nov; 89(3):461-8. PubMed ID: 212917
[TBL] [Abstract][Full Text] [Related]
15. Drugs in the medical treatment of Cushing's syndrome.
Schteingart DE
Expert Opin Emerg Drugs; 2009 Dec; 14(4):661-71. PubMed ID: 19939210
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic possibilities in Cushing's syndrome.
Melby JC
N Engl J Med; 1971 Jul; 285(5):288-9. PubMed ID: 4326258
[No Abstract] [Full Text] [Related]
17. [Effect of large doses of reserpine on the hypothalamo-hypophyseal-adrenal system in Itsenko-Cushing's disease].
Marova EI; Butrova SA; Kolesnikova GS
Probl Endokrinol (Mosk); 1978; 24(2):17-21. PubMed ID: 205862
[TBL] [Abstract][Full Text] [Related]
18. Is it possible to diagnose pituitary-dependent Cushing's disease?
Howlett TA; Rees LH
Ann Clin Biochem; 1985 Nov; 22 ( Pt 6)():550-8. PubMed ID: 3000267
[No Abstract] [Full Text] [Related]
19. Metyrapone is useful only as adjunctive therapy in Cushing's disease.
Orth DN
Ann Intern Med; 1978 Jul; 89(1):128-30. PubMed ID: 208445
[No Abstract] [Full Text] [Related]
20. Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients.
Daniel E; Aylwin S; Mustafa O; Ball S; Munir A; Boelaert K; Chortis V; Cuthbertson DJ; Daousi C; Rajeev SP; Davis J; Cheer K; Drake W; Gunganah K; Grossman A; Gurnell M; Powlson AS; Karavitaki N; Huguet I; Kearney T; Mohit K; Meeran K; Hill N; Rees A; Lansdown AJ; Trainer PJ; Minder AE; Newell-Price J
J Clin Endocrinol Metab; 2015 Nov; 100(11):4146-54. PubMed ID: 26353009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
